Since the microbiome has been strongly implicated in IBD pathogenesis, future studies will be required to determine whether the microbiomes of WT and TLR4-SNP mice differ and whether potential microbial differences affect the observed phenotypic responses to DSS in the two strains. The gene discussed is TLR4; the disease is inflammatory bowel disease.